Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00050583 · ClinicalTrials.gov registry record · Phase 3
Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)
A Phase 3 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 172
- Enrollment target
NCT00050583 is a Phase 3 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 172 participants.
The verdict
NCT00050583, a Phase 3 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 172 participants
- Enrollment target
Study Summary
The purpose of this study is to compare cognitive behavior therapy (CBT) to medical care-as-usual for the treatment of patients with high levels of medically unexplained physical symptoms (Somatization Disorder). A second goal is to examine the effectiveness of CBT in Latinos, since Latinos suffer a relatively high prevalence of Somatization Disorder.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2001-02 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00050583
The ClinicalTrials.gov registry entry for NCT00050583 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT00050583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00050583 about?
NCT00050583 is a clinical study titled "Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)". The purpose of this study is to compare cognitive behavior therapy (CBT) to medical care-as-usual for the treatment of patients with high levels of medically unexplained physical symptoms (Somatization Disorder). A second goal is to examine the effectiveness of CBT in Latinos, since Latinos suffer a...
What is the current status of trial NCT00050583?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 172 participants. The study started on 2001-02. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00050583?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00050583?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.